Laryngeal Mask Supreme During Laparoscopic Gynecologic Surgery
- Disease/Condition
- Anaesthesia
- Drug/Device/Intervention
- Laryngeal Mask Airway-Supreme
- Study type
- Interventional
- Intervention type
- device
- Primary sponsor
- Dokuz Eylul University
- Location
- Izmi̇r, Turkey
- Phase
- N/A
- Start date
- May 01, 2013
- End date
- Apr 01, 2015
- Enrollment
- 108 participants
Asses to Ventilation Parameters,Asses to Peak Pressure,Asses to Mean Pressure
Laryngeal mask (LM) use in gynecological laparoscopy, contrary to widespread opinion, does
 not increase the incidence of gastric aspiration, the failure of ventilation or the risk of
 pulmonary aspiration . LM is presented as an alternative to endo tracheal tube (ETT) in
 spontaneous or positive pressure ventilation (PPV) . LM has gained widespread popularity in
 England for gynecological laparoscopic procedures. In addition in many previous studies LM
 has been successfully shown to provide appropriate lung ventilation in laparoscopic surgical
 interventions .Miller et al. compared the use of ETT, LM-P laparoscopic gynecological
 interventions and identified advantages to LM use. The most important of these advantages was
 that, contrary to tracheal tube techniques for laparoscopic surgeries, use of supraglottic
 laryngeal devices or neuromuscular blocker agents (NBA) were not required during placement.
 Thus for laparoscopic surgeries, compared with the ETT technique, without the need for
 supraglottic laryngeal devices or muscular relaxants, it is easily placed and reduces the
 time spent in the operating room.
 
 Our aim; to compare the use of LM-S and ETT without neuromuscular agents for laparoscopic
 gynecological intervention with positive pressure ventilation from a surgical viewpoint and
 in terms of effect on ventilation parameters.
 
 Secondary aim, comparison of airway morbidity with endotracheal intubation and supraglottic.
- Registry
- ClinicalTrials.gov
- Trial ID
- NCT02125838
- Type
- Device Trial
Access comprehensive clinical trial information for NCT02125838 through Pure Global AI's free database. This phase not specified trial is sponsored by Dokuz Eylul University and is currently Completed. The study focuses on Anaesthesia. Target enrollment is 108 participants.
This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to ClinicalTrials.gov data, helping medical device and pharmaceutical companies navigate clinical research efficiently.